Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,046 across all filing types
Latest filing 2024-10-01 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Update on the performance and demand trends witnessed during the quarter ended September 30, 2024 (Q2 FY25).
Regulatory Filings
2024-10-01 English
Board Meeting — DABUR INDIA LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the pe…
Regulatory Filings
2024-09-24 English
Board Meeting — Financial Results/Dividend
Capital/Financing Update Classification · 90% confidence The document is a notice regarding a Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ending on 30th September 2024, as well as to consider declaration of an interim dividend. The text references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating a regulatory compliance announcement. The document length is short (2488 characters) and primarily serves as an announcement of the upcoming meeting and agenda, not the actual financial results or detailed report. Therefore, it is an announcement related to financial results and dividend declaration, fitting the category of Capital/Financing Update (CAP) rather than the actual Interim/Quarterly Report (IR) or Dividend Notice (DIV).
2024-09-24 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (471 characters) and consists primarily of a digital signature block with no substantive content related to financial performance, management changes, or regulatory announcements. There is no indication of a report, announcement, or detailed information. This matches the pattern of an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-09-24 English
To consider declaration of interim dividend on the equity shares of the Company for the Financial Year 2024-25.
Regulatory Filings Classification · 95% confidence The document is a notification from the company to stock exchanges about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ending September 30, 2024, and to consider declaration of an interim dividend. It is a short announcement informing about the meeting and its agenda, without containing any actual financial data or results. The document length is only 2046 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, such announcements about upcoming board meetings and financial results are best classified as Regulatory Filings (RNS) because they do not contain the financial results themselves but only notify the market about the meeting and agenda. It is not a full Interim/Quarterly Report (IR) because it lacks substantive financial data, nor is it a Notice of Dividend Amount (DIV) because the dividend is only to be considered, not declared yet. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-09-24 English
DABUR INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 ,inter alia, to consider and approve the unaudited financial results ....
Regulatory Filings Classification · 95% confidence The document is a formal notice from the company to stock exchanges about an upcoming Board Meeting scheduled for October 30, 2024. The purpose of the meeting is to consider and approve unaudited financial results for the quarter and half year ending September 30, 2024, and to consider declaration of an interim dividend. The document does not contain any financial data or results itself, but rather announces the meeting where such results will be reviewed and decisions made. The document length is short (2046 characters) and it is clearly an announcement of a future event, not the report or results themselves. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges about upcoming financial disclosures and dividend considerations.
2024-09-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.